2025-11769NoticeWallet

FDA Starts Talks on Another Round of Generic Drug Fees

Published Date: 6/26/2025

Notice

Summary

The FDA is gearing up to renew its Generic Drug User Fee program for 2028-2032 and wants groups like patients, doctors, and scientists to join monthly talks starting fall 2025. These fees help speed up generic drug approvals, so staying involved means smoother, faster access to affordable meds. If you want in, let the FDA know by September 4, 2025, and get ready for some important, ongoing conversations!

Analyzed Economic Effects

2 provisions identified: 1 benefits, 1 costs, 0 mixed.

GDUFA Funding May End After September 2027

The notice states that at the end of September 2027 new legislation will be required for FDA to continue collecting generic drug user fees. If new legislation is not enacted by the end of September 2027, FDA will no longer be able to collect user fees for subsequent fiscal years to fund human generic drug activities.

Opportunity to Join Monthly GDUFA Consultations

If you are a patient or consumer advocacy group, a health care professional, or a scientific or academic expert, you may notify the FDA by September 4, 2025 to join monthly consultation meetings about reauthorizing the Generic Drug User Fee program. Meetings are expected to start in the Fall of 2025 and will be held monthly, in person at the FDA White Oak campus (Silver Spring, MD) and virtually using Microsoft Teams.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Effective Date
6/26/2025
9/4/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register